Global Plasma Protease C1-inhibitor Treatment Market Professional Survey Report 2017

November 2017 | 102 pages | ID: GAF6642A670EN
QYResearch

Abstracts

This report studies Plasma Protease C1-inhibitor Treatment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Shire plc
• CSL Limited
• Sanquin
• Pharming Group N.V.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• by Drug Class
• C1-inhibitors
• Kallikrein Inhibitor (Kalbitor)
• Selective Bradykinin B2 Receptor Antagonist (Firazyr)
• by Dosage Type
• Liquid/Injectable
• Lyophilized

By Application, the market can be split into

• Hospital Pharmacies
• Independent Pharmacies and Outlets

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Plasma Protease C1-inhibitor Treatment Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PLASMA PROTEASE C1-INHIBITOR TREATMENT

1.1 Definition and Specifications of Plasma Protease C1-inhibitor Treatment
  1.1.1 Definition of Plasma Protease C1-inhibitor Treatment
  1.1.2 Specifications of Plasma Protease C1-inhibitor Treatment
1.2 Classification of Plasma Protease C1-inhibitor Treatment
  1.2.1 C1-inhibitors
  1.2.2 Kallikrein Inhibitor (Kalbitor)
  1.2.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
1.3 Applications of Plasma Protease C1-inhibitor Treatment
  1.3.1 Hospital Pharmacies
  1.3.2 Independent Pharmacies and Outlets
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PLASMA PROTEASE C1-INHIBITOR TREATMENT

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Plasma Protease C1-inhibitor Treatment
2.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
2.4 Industry Chain Structure of Plasma Protease C1-inhibitor Treatment

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PLASMA PROTEASE C1-INHIBITOR TREATMENT

3.1 Capacity and Commercial Production Date of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016

4 GLOBAL PLASMA PROTEASE C1-INHIBITOR TREATMENT OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Plasma Protease C1-inhibitor Treatment Capacity and Growth Rate Analysis
  4.2.2 2016 Plasma Protease C1-inhibitor Treatment Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Plasma Protease C1-inhibitor Treatment Sales and Growth Rate Analysis
  4.3.2 2016 Plasma Protease C1-inhibitor Treatment Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Plasma Protease C1-inhibitor Treatment Sales Price
  4.4.2 2016 Plasma Protease C1-inhibitor Treatment Sales Price Analysis (Company Segment)

5 PLASMA PROTEASE C1-INHIBITOR TREATMENT REGIONAL MARKET ANALYSIS

5.1 North America Plasma Protease C1-inhibitor Treatment Market Analysis
  5.1.1 North America Plasma Protease C1-inhibitor Treatment Market Overview
  5.1.2 North America 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.1.4 North America 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis
5.2 China Plasma Protease C1-inhibitor Treatment Market Analysis
  5.2.1 China Plasma Protease C1-inhibitor Treatment Market Overview
  5.2.2 China 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.2.4 China 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis
5.3 Europe Plasma Protease C1-inhibitor Treatment Market Analysis
  5.3.1 Europe Plasma Protease C1-inhibitor Treatment Market Overview
  5.3.2 Europe 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.3.4 Europe 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis
5.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Analysis
  5.4.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Overview
  5.4.2 Southeast Asia 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.4.4 Southeast Asia 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis
5.5 Japan Plasma Protease C1-inhibitor Treatment Market Analysis
  5.5.1 Japan Plasma Protease C1-inhibitor Treatment Market Overview
  5.5.2 Japan 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.5.4 Japan 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis
5.6 India Plasma Protease C1-inhibitor Treatment Market Analysis
  5.6.1 India Plasma Protease C1-inhibitor Treatment Market Overview
  5.6.2 India 2012-2017E Plasma Protease C1-inhibitor Treatment Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price Analysis
  5.6.4 India 2016 Plasma Protease C1-inhibitor Treatment Market Share Analysis

6 GLOBAL 2012-2017E PLASMA PROTEASE C1-INHIBITOR TREATMENT SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Plasma Protease C1-inhibitor Treatment Sales by Type
6.2 Different Types of Plasma Protease C1-inhibitor Treatment Product Interview Price Analysis
6.3 Different Types of Plasma Protease C1-inhibitor Treatment Product Driving Factors Analysis
  6.3.1 by Drug Class of Plasma Protease C1-inhibitor Treatment Growth Driving Factor Analysis
  6.3.2 by Dosage Type of Plasma Protease C1-inhibitor Treatment Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PLASMA PROTEASE C1-INHIBITOR TREATMENT SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Plasma Protease C1-inhibitor Treatment Consumption by Application
7.2 Different Application of Plasma Protease C1-inhibitor Treatment Product Interview Price Analysis
7.3 Different Application of Plasma Protease C1-inhibitor Treatment Product Driving Factors Analysis
  7.3.1 Hospital Pharmacies of Plasma Protease C1-inhibitor Treatment Growth Driving Factor Analysis
  7.3.2 Independent Pharmacies and Outlets of Plasma Protease C1-inhibitor Treatment Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PLASMA PROTEASE C1-INHIBITOR TREATMENT

8.1 Shire plc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Shire plc 2016 Plasma Protease C1-inhibitor Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Shire plc 2016 Plasma Protease C1-inhibitor Treatment Business Region Distribution Analysis
8.2 CSL Limited
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 CSL Limited 2016 Plasma Protease C1-inhibitor Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 CSL Limited 2016 Plasma Protease C1-inhibitor Treatment Business Region Distribution Analysis
8.3 Sanquin
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sanquin 2016 Plasma Protease C1-inhibitor Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanquin 2016 Plasma Protease C1-inhibitor Treatment Business Region Distribution Analysis
8.4 Pharming Group N.V.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Pharming Group N.V. 2016 Plasma Protease C1-inhibitor Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Pharming Group N.V. 2016 Plasma Protease C1-inhibitor Treatment Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET

9.1 Global Plasma Protease C1-inhibitor Treatment Market Trend Analysis
  9.1.1 Global 2017-2022 Plasma Protease C1-inhibitor Treatment Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Plasma Protease C1-inhibitor Treatment Sales Price Forecast
9.2 Plasma Protease C1-inhibitor Treatment Regional Market Trend
  9.2.1 North America 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
  9.2.2 China 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
  9.2.3 Europe 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
  9.2.5 Japan 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
  9.2.6 India 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Forecast
9.3 Plasma Protease C1-inhibitor Treatment Market Trend (Product Type)
9.4 Plasma Protease C1-inhibitor Treatment Market Trend (Application)

10 PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKETING TYPE ANALYSIS

10.1 Plasma Protease C1-inhibitor Treatment Regional Marketing Type Analysis
10.2 Plasma Protease C1-inhibitor Treatment International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Plasma Protease C1-inhibitor Treatment by Region
10.4 Plasma Protease C1-inhibitor Treatment Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PLASMA PROTEASE C1-INHIBITOR TREATMENT

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Plasma Protease C1-inhibitor Treatment
Table Product Specifications of Plasma Protease C1-inhibitor Treatment
Table Classification of Plasma Protease C1-inhibitor Treatment
Figure Global Production Market Share of Plasma Protease C1-inhibitor Treatment by Type in 2016
Figure C1-inhibitors Picture
Table Major Manufacturers of C1-inhibitors
Figure Kallikrein Inhibitor (Kalbitor) Picture
Table Major Manufacturers of Kallikrein Inhibitor (Kalbitor)
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Picture
Table Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Table Applications of Plasma Protease C1-inhibitor Treatment
Figure Global Consumption Volume Market Share of Plasma Protease C1-inhibitor Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Table Major Consumers in Hospital Pharmacies
Figure Independent Pharmacies and Outlets Examples
Table Major Consumers in Independent Pharmacies and Outlets
Figure Market Share of Plasma Protease C1-inhibitor Treatment by Regions
Figure North America Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Figure China Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Figure Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Figure Japan Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Figure India Plasma Protease C1-inhibitor Treatment Market Size (Million USD) (2012-2022)
Table Plasma Protease C1-inhibitor Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Plasma Protease C1-inhibitor Treatment in 2016
Figure Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
Figure Industry Chain Structure of Plasma Protease C1-inhibitor Treatment
Table Capacity and Commercial Production Date of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Plasma Protease C1-inhibitor Treatment Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Plasma Protease C1-inhibitor Treatment 2012-2017
Figure Global 2012-2017E Plasma Protease C1-inhibitor Treatment Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Plasma Protease C1-inhibitor Treatment Market Size (Value) and Growth Rate
Table 2012-2017E Global Plasma Protease C1-inhibitor Treatment Capacity and Growth Rate
Table 2016 Global Plasma Protease C1-inhibitor Treatment Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Plasma Protease C1-inhibitor Treatment Sales (K Units) and Growth Rate
Table 2016 Global Plasma Protease C1-inhibitor Treatment Sales (K Units) List (Company Segment)
Table 2012-2017E Global Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Table 2016 Global Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure North America 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure North America 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure China 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure China 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure Europe 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure Europe 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure Southeast Asia 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure Southeast Asia 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure Japan 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure Japan 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Plasma Protease C1-inhibitor Treatment 2012-2017E
Figure India 2012-2017E Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit)
Figure India 2016 Plasma Protease C1-inhibitor Treatment Sales Market Share
Table Global 2012-2017E Plasma Protease C1-inhibitor Treatment Sales (K Units) by Type
Table Different Types Plasma Protease C1-inhibitor Treatment Product Interview Price
Table Global 2012-2017E Plasma Protease C1-inhibitor Treatment Sales (K Units) by Application
Table Different Application Plasma Protease C1-inhibitor Treatment Product Interview Price
Table Shire plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Shire plc Plasma Protease C1-inhibitor Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Shire plc Plasma Protease C1-inhibitor Treatment Business Region Distribution
Table CSL Limited Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSL Limited Plasma Protease C1-inhibitor Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 CSL Limited Plasma Protease C1-inhibitor Treatment Business Region Distribution
Table Sanquin Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanquin Plasma Protease C1-inhibitor Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanquin Plasma Protease C1-inhibitor Treatment Business Region Distribution
Table Pharming Group N.V. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Business Region Distribution
Figure Global 2017-2022 Plasma Protease C1-inhibitor Treatment Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Plasma Protease C1-inhibitor Treatment Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Plasma Protease C1-inhibitor Treatment Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Plasma Protease C1-inhibitor Treatment Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Plasma Protease C1-inhibitor Treatment by Type 2017-2022
Table Global Consumption Volume (K Units) of Plasma Protease C1-inhibitor Treatment by Application 2017-2022
Table Traders or Distributors with Contact Information of Plasma Protease C1-inhibitor Treatment by Region